Search Results

‘SKINNY’ SENATE HEALTHCARE BILL WOULD THREATEN ACCESS TO CANCER TREATMENT

Rye Brook, N.Y. (July , ) – The U.S. Senate has initiated debate on the healthcare bill, and Senate leaders are indicating they intend to advance leg…

After Cancer Treatment: When Going Back to School isn’t Exciting

More than , children are affected by leukemia and lymphoma each year. These blood cancers account for about percent of all childhood cancers. Fortun…

Magrolimab Receives FDA Breakthrough Therapy Designation for Treatment of MDS

FOSTER CITY, Calif., September , - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted …

Managing blood cancer treatment side effects in children and teens

Treatment side effects may last well after treatment is completed or may be permanent. 

TCR T cells for the treatment of SRSF2 mutant myeloid neoplasms

Mutations in the RNA splicing factor gene SRSF2 occur in % of patients with MDS, % of patients with chronic myelomonocytic leukemia (CMML), and % of A…

Choosing a blood cancer specialist or treatment center for young adults

After receiving a blood cancer diagnosis, you will want to find a blood cancer specialist or choose a treatment center. Here’s how.

Long-term and late effects of cancer treatment in young adults

effects can linger for months or years after therapy. Heart disease and other cancers can appear years after treatment.

FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia

Asciminib provides another option to help CML patients live longer, healthier lives RYE BROOK, N.Y., December , – The U.S. Food and Drug Administrati…

New Combination Treatment Improves Outcomes for People with Follicular Lymphoma

WASHINGTON, (June , ) – The U.S. Food and Drug Administration recently approved (Monjuvi®) for use in combination with rituximab and lenalidomide to …

Niclosamide for the Treatment of Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Niclosamide is an FDA approved drug that is well tolerated and acts synergistically with chemotherapy to kill AML cells. We will conduct a Phase I cl…

Development of mutant GTPase-specific degraders for peripheral T cell lymphoma treatment

This project aims to develop targeted therapies against peripheral T cell lymphoma (PTCL), a diverse group of aggressive blood cancers with poor clini…

Staying Connected®: Facilitating the Learning Experience During & After Cancer Treatment

Insurance Inequities in Hodgkin Lymphoma Treatment and Survivorship in the Southeast

Black and Hispanic individuals diagnosed with Hodgkin lymphoma (HL) face worse survival rates across all ages. Using an innovative data source, this s…

Hematopoietic Cell Transplantation as Treatment for Blood Cancers: The Team Approach

Let’s Talk About CAR T-Cell Therapy as a Treatment Option: Blood Cancers

Treatment Advancements for Acute Lymphoblastic Leukemia (ALL) in Children and Adults

New Rule Could Strip Health Coverage From Cancer Patients Undergoing Treatment

WASHINGTON, June , – Today, the Centers for Medicare & Medicaid Services (CMS) issued a new interim final rule on the implementation of Medicaid work…

Closer to a Cure Inspires & Educates About Treatment Advances of Blood Cancers

On Tuesday, April , top researchers and clinicians from UCLA joined The Leukemia & Lymphoma Society to share updates on recent innovations in treating…

Generations of Impact: Ensuring New Cancer Treatments for Those to Come

View on PR Newswire here.

Ushering In a New Era of Pediatric Blood Cancer Treatment and Care

Long-term and late effects of cancer treatment in children and teens

Global Partnership to Fund Groundbreaking Research in Treatment of Multiple Myeloma

Groundbreaking research aimed at translating novel chimeric antigen receptor (CAR) therapies into improved treatment for multiple myeloma is the late…

Multiple Myeloma Patients Cancer Free Five Years after Single CAR-T Treatment

LLS provided critical funding at earliest stages and provides ongoing funding today June , – A new report is opening the possibility that multiple m…

Detection and treatment of Adult T cell leukemia/lymphoma in the premalignant stage.

Clonally expanded T cells carrying somatic mutations circulate in the premalignant phase of Adult T cell leukemia/lymphoma (ATL). We will develop of …

FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular Lymphoma

“This new treatment has the potential to help patients with this cancer achieve remission,” says LLS Chief Scientific Officer Dr. Lee Greenberger.